The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients

Clinical trial NCT01397240 · UNKNOWN

Trial details

NCT number: NCT01397240
Sponsor: Daewoong Pharmaceutical Co. LTD.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Patients Taking Low-dose Aspirin

Start date: 2011-07-01
Primary completion: 2012-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.